Results 241 to 250 of about 487,301 (268)

Molecular Glue cc‐885 Inhibits VHL‐Deficient Clear Cell Renal Cell Carcinoma via ETS1 Degradation

Advanced Science, EarlyView.
VHL‐deficient kidney cancer lacks effective treatments. This study reveals that the molecular glue degrader cc‐885 hijacks the cellular recycling system to selectively destroy the oncogenic protein ETS1, effectively killing VHL‐mutant tumors. Combining CC‐885 with the approved drug belzutifan achieves powerful synergy, offering a promising new ...
Taowei Yang, Qihao Li, Kun Ye, Kezhi Liu, Mi Zhou, Minyu Chen, Lican Liao, Kangbo Huang, Zhu Wang, Qiong Deng, Jieyan Wang, Meiyu Jin, Xu Chen, Hui Liang, Jiaxing Zhang, Junhang Luo   +15 more
wiley   +1 more source

Editorial: Discovery of small molecule lead compounds: a driving force to unravel new anti-cancer targets and mechanisms, volume III. [PDF]

Front Oncol
Zhang Y, Fu L, Wang Y.
europepmc   +1 more source

Development of a questionnaire to assess the medication literacy of patients receiving oral anticancer drugs. [PDF]

Sci Rep
Fehrmann W, Moritz AK, Basten V, Schuler MK, Schmid M, Ernstmann N, Jaehde U.   +6 more
europepmc   +1 more source

Rare-Earth Elements at the Interface of Chemistry and Cancer Therapy. [PDF]

Molecules
Goldiș C, Pașcalău NA, Racoviceanu R, Maksimovic T, Jorgovan M, Atyim E, Bătrîna O, Mioc M, Șoica C.   +8 more
europepmc   +1 more source

Enhancing anticancer peptide discovery: A fusion-centric framework with conditional diffusion for prediction and generation. [PDF]

PLoS Comput Biol
Li B, Zhang X, Huang Z, Tiwari P, Zou Q, Ding Y, Guo X.   +6 more
europepmc   +1 more source

Metabolic profiling and systems biology analysis of Flammulina filiformis Fv19 extract: an integrated computational and experimental approach for dual anti-cancer and immunomodulatory therapy. [PDF]

BMC Biotechnol
El-Sayed H, Osman ME, Mohamed ET, Nady S, Abd El-Hameed RM.   +4 more
europepmc   +1 more source

Fifth International Conference of Anticancer Research October 17 - 22, 1995, Corfu, Greece

, 1995
International Conference of Anticancer Research 1995 Kerkira, Ablashi, Dharam V.   +1 more
core  

Evolution of Thiosemicarbazones: From First- to Second-Generation Metal Chelators and Their Reactive Oxygen Species-Mediated Effects in Melanoma. [PDF]

ChemistryOpen
Alim R, Andrew SD, Parkinson CJ.
europepmc   +1 more source

(Anticancer Res., 13:973-978)Metabolism of radiolabelled 18:2n 6 and 18:3n 6 by NIH-3T3 cells and the DT subclone

, 2014
Elliot, M., Y. S. Huang, De Antueno, R.J., Horrobin, D.F., Cantrill, R.C., Ells, G.W.   +5 more
core  

Some of the next articles are maybe not open access.

Related searches:

The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies

Ca-A Cancer Journal for Clinicians, 2022
Sharon Elad, Noam Yarom
exaly